TDB-DST extends support to M/s TechInvention Lifecare Ltd., Navi Mumbai for Indigenous Development of 16-Valent Pneumococcal Conjugate Vaccine
The Technology Development Board (TDB), Department of Science & Technology, Government of India, has sanctioned financial support to M/s TechInvention Lifecare Limited, Navi Mumbai for the establishment of a commercial-scale cGMP facility for the production of an indigenously developed 16-valent Pneumococcal Conjugate Vaccine (PCV-16). The supported project aims to strengthen India’s capability in next-generation conjugate vaccines and reduce long-term dependence on imported products through domestic innovation and manufacturing.







